|
Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study. |
|
|
Research Funding - Eisai (Inst); GRAIL (Inst); Janssen Diagnostics (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst) |
Travel, Accommodations, Expenses - Agena Bioscience; Celgene; Cynvenio Biosystems; GRAIL; Menarini Silicon Biosystems; Merck |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL; Thermo Fisher Scientific |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL; Illumina |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca |
|
Other Relationship - Ambry Genetics |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
Consulting or Advisory Role - GenomeDx; Genomic Health |
Speakers' Bureau - Genomic Health |
|
|
Employment - GRAIL; Myriad Genetics |
Stock and Other Ownership Interests - GRAIL; Myriad Genetics |
|
|
Leadership - Infinity Pharmaceuticals; Varian Medical Systems |
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems |
Consulting or Advisory Role - GRAIL; Lilly; Novartis |